ALLERGIC RHINITIS IN PRE-SCHOOL CHILDREN LIVING IN URBAN SETTINGS OF THE ALTAI REGION: A POPULATION-BASED CROSS-SECTIONAL STUDY

Background. It is necessary to study the prevalence and risk factors of allergic rhinitis (AR) among pre-school children in order to develop a disease prevention strategy.

Objective. Our aim was to study the prevalence, clinical and allergological features, and risk factors for AR in pre-school children living in urban settings of the Altai Region.

Methods. At the screening stage, the study enrolled children aged 3–6 years attending pre-school educational institutions in 5 cities of the Altai Region. AR symptoms were determined using the ISAAC questionnaire. The AR was diagnosed if ≥ 2 symptoms (rhinorrhea, nasal breathing difficulty, itching in the nasal cavity, repetitive sneezing) lasted ≥ 1 h with a positive prick test and/or a blood level of specific IgE > 0.35 kU/L to at least one allergen (total 11).

Results. The prevalence of AR in urban children aged 3–6 years (n = 3,205) was 10.6%; 48% of them were previously diagnosed with AR. 85% of children had a persistent course of the disease; 69% had mild AR. Most often, there was established sensitization to house dust mites (61.6%), birch pollen (40.9%), and cat fur (19.4%). The risk factors for AR were family history of allergies [odds ratio (OR) 4.2; 95% confidence interval (CI) 3.5–5.9], masculine (OR 2.8, 95% CI 1.9–4.0), smoking parents (OR 1.8, 95% CI 1.2–2.9), nonadherence to a regimen/dosage of vitamin D3 intake in infancy (OR 1.8, 95% CI 1.2–2.8), presence of asthma-like symptoms (OR 10.2, 95% CI 7.2–14.5), and manifestations of atopic dermatitis (OR 6.0, 95% CI 4.2–8.5).

Conclusion. AR occurs in every tenth pre-school child (mainly of mild severity and persistent course), every second disease among them was diagnosed for the first time. Sensitization occurs to typical for childhood allergens. The risk factors for AR are family history of allergies, masculine, passive smoking, ignoring the recommendations of taking vitamin D3 in infancy, the presence of atopic dermatitis, and asthma-like symptoms.

1. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi-country cross-sectional surveys. Lancet. 2006;368(9537): 733–743. doi: 10.1016/S0140-6736(06)69283-0.

2. McNeill G, Tagiyeva N, Aucott L, et al. Changes in the prevalence of asthma, eczema and hay fever in pre-pubertal children: a 40-year perspective. Paediatr Perinat Epidemiol. 2009;23(6):506–512. doi: 10.1111/j.1365-3016.2009.01057.x.

3. Schernhammer ES, Vutuc C, Waldhor T, Haidinger G. Time trends of the prevalence of asthma and allergic disease in Austrian children. Pediatr Allergy Immunol. 2008;19(2):125–131. doi: 10.1111/j.1399-3038.2007.00597.x.

4. Ait-Khaled N, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123–148. doi: 10.1111/j.13989995.2008.01884.x.

5. Deng Q, Lu C, Yu Y, et al. Early life exposure to traffic-related air pollution and allergic rhinitis in preschool children. Respir Med. 2016;121:67–73. doi: 10.1016/j.rmed.2016.10.016.

6. Huang C, Liu Y, Hu Y, et al. Updated Prevalences of asthma, allergy, and airway symptoms and a systematic review of trends over time for childhood asthma in Shanghai, China. PLoS One. 2015;10(4):e0121577. doi: 10.1371/journal.pone.0121577.

7. Kim DH, Park YS, Jang HJ, et al. Prevalence and allergen of allergic rhinitis in Korean children. Am J Rhinol Allergy. 2016;30(3): 72–78. doi: 10.2500/ajra.2013.27.4317.

8. Indinnimeo L, Porta D, Forastiere F, et al. Prevalence and risk factors for atopic disease in a population of preschool children in Rome: challenges to early intervention. Int J Immunopathol Pharmacol. 2016;29(2):308–319. doi: 10.1177/0394632016635656.

9. Hill DA, Grundmeier RW, Ram G, Spergel JM. The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study. BMC Pediatrics. 2016;16:133–141. doi: 10.1186/s12887-016-0673-z.

10. Bolat E, Arikoqlu T, Sunqur MA, et al. Prevalence and risk factors for wheezing and allergic diseases in preschool children: a perspective from the Mediterranean coast of Turkey. Allergol Immunopathol (Madr). 2017;45(4):362–368. doi: 10.1016/j.aller.2017.01.002.

11. Peters RL, Koplin JJ, Gurrin LC, et al. The prevalence of food allergy and other allergic diseases in early childhood in a populationbased study: HealthNuts age 4-year follow-up. J Allergy Clin Immunol. 2017;140(1):145–153.e8. doi: 10.1016/j.jaci.2017.02.019.

12. Yoon J, Choi YJ, Lee E, et al. Allergic rhinitis in preschool children and the clinical utility of FeNO. Allergy Asthma Immunol Res. 2017;9(4):314–321. doi: 10.4168/aair.2017.9.4.314.

13. Sadchikova TL, Belan EB, Zheltova AA, et al. The prevalence of the allergic rhinitis in preschool children in Volgograd. Rossiiskii allergologicheskii zhurnal. 2016;(3–2):30–31. (In Russ).

14. Standartizirovannye ehpidemiologicheskie issledovaniya allergicheskikh zabolevanii u detei. Adaptatsiya programmy «Mezhdunarodnoe issledovanie astmy i allergii «ISAAC» v Rossii. Posobie dlya vrachei. Moscow; 1998. 30 p. (In Russ).

15. Shahova NV, Kamaltynova EM, Lobanov YuF, et al. Prevalence and risk factors of asthma-like symptoms and allergic rhinitis in preschool children. Pul’monologiia (Moscow, Russia). 2017;27(5):636– 642. (In Russ). doi: 10.18093/0869-0189-2017-27-5-636-642.

16. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63 Suppl 86:8–160. doi: 10.1111/j.1398-9995.2007.01620.x.

17. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test — European standards. Clin Transl Allergy. 2013;3(1):3. doi: 10.1186/2045-7022-3-3.

18. Allergicheskii rinit. Klinicheskie rekomendatsii. Moscow; 2018. (In Russ). Доступно по: http://nrcii.ru/docs/2.allergic_rhinitis.pdf. Ссылка активна на 18.05.2018.

19. ginasthma.org [Internet]. Global Initiative for Asthma. Global strategy for Asthma management and prevention. Global Initiative for Asthma 2018 [updated 2018; cited 2018 Apr 18]. Available at: https://ginasthma.org/2018-gina-report-global-strategy-forasthma-management-and-prevention.

20. Fedorova OS. Klinikoepidemiologicheskaya kharakteristika pishchevoi allergii u detei v mirovom ochage opistorkhoza. [dissertation] Tomsk; 2010. 264 p. (In Russ). Доступно по http://medical-diss.com/medicina/klinikoepidemiologicheskaya-harakteristika-pischevoy-allergii-u-detey-vmirovom-ochage-opistorhoza. Ссылка активна на 18.05.2018.

21. Kong WJ, Chen JJ, Zheng ZY, et al. Prevalence of allergic rhinitis in 3–6–year-old children in Wuhan of China. Clin Exp Allergy. 2009;39(6):869–874. doi: 10.1111/j.1365-2222.2009.03206.x.

22. Zhang YM, Zhang J, Liu SL, et al. Prevalence and associated risk factors of allergic rhinitis in preschool children in Beijing. Laryngoscope. 2013;123(1):28–35. doi: 10.1002/lary.23573.

23. Shimojo N. Prevalence of allergic rhinitis in 3-6-year-old children in Chiba City, Japan. Proceedings of the XXIV World Allergy Congress; 2015 Oct 14–17; Seoul, Korea. World Allergy Organ J. 2015; 9 Suppl 1:A376.

24. Okada Y, Kumagai H, Morikawa Y, Akasawa A. Epidemiology of pediatric allergic diseases in the Ogasawara Islands. Allergol Int. 2016;65(1):37–43. doi: 10.1016/j.alit.2015.06.010.

25. Alm B, Goksor E, Thengilsdottir H, et al. Early protective and risk factors for allergic rhinitis at age 4 1/2 yr. Pediatr Allergy Immunol. 2011;22(4):398–404. doi: 10.1111/j.1399-3038.2011.01153.x.

26. Cho YM, Ryu SH, Choi MS, et al. Asthma and allergic diseases in preschool children in Korea: findings from the pilot study of the Korean Surveillance System for Childhood Asthma. J Asthma. 2014;51(4):373–379. doi: 10.3109/02770903.2013.876648.

27. Morais-Almeda M, Santos N, Pereira AM, et al. Prevalence and classification of rhinitis in preschool children in Portugal: a nationwide study. Allergy. 2013;68(10):1278–1288. doi: 10.1111/all.12221.

28. Tatcher JD, Gruzieva O, Pershagen G, et al. Pre- and postnatal exposure to parental smoking and allergic disease through adolescence. Pediatrics. 2014;134(3):428–234. doi: 10.1542/peds.2014-0427.

29. Peroni GD, Piacentini G, Alfonsi L, et al. Rhinitis in pre-school children: prevalence, association with allergic disease and risk factors. Clin Exp Allergy. 2003;33(10):1349–1354. doi: 10.1046/j.1365-2222.2003.01766.x.

30. Bener A, Ehlayel MS, Bener HZ, et al. The impact of Vitamin D deficiency on asthma, allergic rhinitis and wheezing in children: an emerging public health problem. J Family Community Med. 2014;21(3):154–161. doi: 10.4103/2230-8229.142967.

31. Yoon SH, Kim JY, Kim YH, et al. Association between the serum 25-hydroxyvitamin D level and allergic rhinitis in Korean children. Allergy Asthma Respir Dis. 2016;4(6):423–428. doi: 10.4168/aard.2016.4.6.423.

32. Lee SY, Kwon JW, Seo JH, et al. Prevalence of atopy and allergic diseases in Korean children: associations with a farming environment and rural lifestyle. Int Arch Allergy Immunol. 2012;158(2):168–174. doi: 10.1159/000330820.

33. Hajavi J, Tolide-ie HR, Rastgoie Chavoshlu S, et al. Do rural and urban children have different prevalence of allergic disorders in Gonabad? Horizon Med Sci. 2012;18(2):21–26.

34. Braun-Fahrlander C, Wuthrich B, Gassner M, et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. SCARPOL-team. Swiss Study on Childhood Allergy and Respiratory Symptom with respect to Air Pollution and Climate. International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 1997;8(2):75–82. doi: 10.1111/j.1399-3038.1997.tb00147.x.

35. Kim H, Levin L, LeMasters GK, et al. Validating childhood symptoms with physician-diagnosed allergic rhinitis. Ann Allergy Asthma Immunol. 2012;108(4):228–231. doi: 10.1016/j.anai. 2012.02.004.